Chronic Lymphocytic Leukemia Clinical Trials in Reims
3 recruitingReims, France
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
BeOne Medicines630 enrolled155 locationsNCT06943872
Recruiting
Not Applicable
Description of the Immune Deficiency in Patients With Untreated Chronic Lymphocytic Leukemia and Search for Predictive Factors of Infectious Risk
Chronic Lymphocytic Leukemia
CHU de Reims75 enrolled1 locationNCT06475469
Recruiting
Venetoclax Resistance Landscape in Chronic Lymphocytic Leukemia
Chronic Lymphocytic LeukemiaRefractory Chronic Lymphocytic LeukemiaCLL+2 more
University Hospital, Clermont-Ferrand50 enrolled14 locationsNCT05246345